𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Factor V Leiden improves in vivo hemostasis in murine hemophilia models

✍ Scribed by A. SCHLACHTERMAN; J. SCHUETTRUMPF; J.-H. LIU; C. F. FREGUIA; R. TOSO; M. PONCZ; R. M. CAMIRE; V. R. ARRUDA

Book ID
109149259
Publisher
John Wiley and Sons
Year
2005
Tongue
English
Weight
348 KB
Volume
3
Category
Article
ISSN
1538-7933

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Cerebral infarct associated with factor
Cerebral infarct associated with factor V Leiden mutation in a boy with hemophilia A
✍ Olcay, Lale; GΓΌrgey, Aytemiz; Topaloğlu, Haluk; Altay, Sedat; Parlak, HΓΌlya; Fir πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 English βš– 77 KB πŸ‘ 2 views

An 11-year-old boy with mild hemophilia A was admitted to our hospital because of focal convulsions. Magnetic resonance imaging showed an old occipital infarct. Protein C, S, antithrombin III, anticardiolipin antibodies and fibrinogen were normal. Heterozygosity for factor V Leiden mutation was dete

Phosphatidylserine containing liposomes
Phosphatidylserine containing liposomes reduce immunogenicity of recombinant human factor VIII (rFVIII) in a murine model of hemophilia A
✍ Karthik Ramani; Razvan D. Miclea; Vivek S. Purohit; Donald E. Mager; Robert M. S πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 257 KB

Factor VIII (FVIII) is a multidomain protein that is deficient in hemophilia A, a clinically important bleeding disorder. Replacement therapy using recombinant human FVIII (rFVIII) is the main therapy. However, approximately 15-30% of patients develop inhibitory antibodies that neutralize rFVIII act